Yatsen Holding Secures $120 Million Strategic Investment
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Should l Buy YSG?
Source: seekingalpha
- Strategic Investment Agreement: Yatsen Holding has secured approximately $120 million in RMB-denominated convertible senior notes through a definitive agreement with Trustar Capital and founder Jinfeng Huang, indicating strong growth potential in the beauty industry.
- Clear Use of Funds: The financing will be allocated for research and development, supply chain integration, overseas expansion, and strategic mergers, aimed at supporting the company's sustained growth and enhancing its competitive position in the market.
- Favorable Note Terms: The first tranche of notes is expected to be issued in March 2026 with an interest rate of 1.5% per annum, convertible into Class A shares after 364 days at a conversion price of $4.63, representing a 20% premium over the average price prior to the agreement.
- Support from Trustar Capital: Trustar Capital will leverage its network to help Yatsen enhance its position in the beauty industry and support its global expansion through expertise in acquisitions and integrations, further solidifying the strategic alliance between the two parties.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy YSG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on YSG
About YSG
Yatsen Holding Ltd is a holding company primarily engaged in the development, manufacturing and sales of beauty products. The Company operates three segments. The Color Cosmetics Brands segment is primarily engaged in the provision of color cosmetics including lip, eye and face products through the brands such as Perfect Diary, Little Ondine and Pink Bear. The Skincare Brands segment is primarily engaged in the provision of skincare products including face serums, face creams, makeup removers, masks, toners, eye creams and cleansers through the brands such as Galenic, DR.WU, Eve Lom and EANTiM. The Others segment is primarily engaged in the provision of products such as beauty tools and kits, sun screen and beauty devices.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strategic Investment Agreement: Yatsen Holding has secured approximately $120 million in RMB-denominated convertible senior notes through a definitive agreement with Trustar Capital and founder Jinfeng Huang, indicating strong growth potential in the beauty industry.
- Clear Use of Funds: The financing will be allocated for research and development, supply chain integration, overseas expansion, and strategic mergers, aimed at supporting the company's sustained growth and enhancing its competitive position in the market.
- Favorable Note Terms: The first tranche of notes is expected to be issued in March 2026 with an interest rate of 1.5% per annum, convertible into Class A shares after 364 days at a conversion price of $4.63, representing a 20% premium over the average price prior to the agreement.
- Support from Trustar Capital: Trustar Capital will leverage its network to help Yatsen enhance its position in the beauty industry and support its global expansion through expertise in acquisitions and integrations, further solidifying the strategic alliance between the two parties.
See More
- Significant Financing: Yatsen has entered into an agreement with Trustar Capital to issue convertible senior notes totaling approximately $120 million, divided into two tranches, demonstrating the company's strong appeal and capability in capital markets.
- Clear Strategic Use: The proceeds from this financing will be allocated to future product R&D, global supply chain integration, and overseas market expansion, indicating Yatsen's commitment to driving business growth through diversified investments and enhancing market competitiveness.
- Increased Management Confidence: Founder and CEO Jinfeng Huang's personal investment underscores his strong confidence in the company's long-term prospects, which is expected to further enhance investor trust and support for Yatsen.
- Deepened Partnership: Trustar Capital will leverage its extensive network to assist Yatsen in capturing strategic synergies within the beauty industry, facilitating its global expansion through cross-border M&A and solidifying its position in the global beauty market.
See More
- Investment Agreement Signed: Yatsen has entered into a definitive agreement with Trustar Capital and founder Jinfeng Huang to issue approximately $120 million in convertible senior notes in two tranches, reflecting strong confidence in the company's long-term prospects.
- Clear Use of Proceeds: The funds will be allocated for future product R&D, global supply chain integration, and overseas market expansion, aimed at driving business growth and enhancing market competitiveness.
- Strategic Partnership Deepened: Trustar Capital will leverage its extensive network to assist Yatsen in capturing strategic synergies within the beauty industry, facilitating global expansion and cross-border M&A to solidify its market position.
- Favorable Note Terms: The notes carry an interest rate of 1.5% per annum and can be converted into the company's ordinary shares after 364 days, with a conversion price of $4.63 per share, reflecting a 20% premium, enhancing potential returns for investors.
See More
- Earnings Decline: Yatsen Holding Ltd reported adjusted earnings of 7 cents per share for Q4, down from 14 cents in the previous year, indicating a significant decline in profitability that could undermine investor confidence.
- Sales Growth: Despite the drop in earnings, Yatsen's sales increased from $157.347 million to $197.258 million, suggesting that the company still has growth potential in market demand, which may lay the groundwork for future recovery.
- Stock Price Volatility: Yatsen's shares fell 10.1% to $4.00 in pre-market trading, reflecting a negative market reaction to its earnings report, which could lead to increased selling pressure from investors in the short term.
- Market Trends: U.S. stock futures were generally lower, with Dow futures falling around 1%, indicating a broader market sentiment that may have a ripple effect on Yatsen and other stocks' performance.
See More
- Profit Turnaround: Yatsen Holding reported a net income of RMB 3.0 million in Q4, a significant turnaround from a net loss of RMB 378.8 million in the same period last year, indicating improved profitability and boosting investor confidence.
- Earnings Per Share Recovery: The diluted ADS net income was RMB 0.08, a substantial recovery from last year's net loss of RMB 3.98, demonstrating the company's success in cost control and market strategy.
- Non-GAAP Income Decline: Although the Q4 non-GAAP net income was RMB 41.2 million, down from RMB 107.0 million year-over-year, it still reflects a degree of stability in the company's adjusted profitability.
- Optimistic Future Outlook: The company expects total net revenues for Q1 2026 to range between RMB 958.6 million and RMB 1.08 billion, representing a year-over-year increase of approximately 15% to 30%, indicating a positive outlook on future market demand.
See More
- Significant Revenue Growth: Yatsen's total net revenue for 2025 reached RMB 4.3 billion (approximately USD 614.6 million), marking a 26.7% year-over-year increase, primarily driven by a 63.5% rise in skincare brand revenues, showcasing the company's strong market performance and brand strength.
- Stable Gross Margin: In Q4 2025, gross profit amounted to RMB 1.07 billion (approximately USD 153.2 million) with a gross margin of 77.7%, remaining largely unchanged from the previous year, indicating effective strategies in cost control and product mix optimization.
- Substantial Reduction in Operating Loss: The operating loss for Q4 2025 was only RMB 12.7 million (approximately USD 1.8 million), a significant improvement from RMB 390.7 million in the same period last year, reflecting the company's success in operational efficiency and cost management.
- Optimistic Future Outlook: The company anticipates total revenues for Q1 2026 to be between RMB 958.6 million and RMB 1.08 billion, representing a year-over-year increase of approximately 15% to 30%, demonstrating confidence in market demand and potential for sustained growth.
See More









